₹35.38
▲ +3.92 +12.46%
10 Sept 2026
NSE Listed · Pharmaceuticals
Biofil Chemicals & Pharmaceuticals Ltd. (BIOFILCHEM)
Volume: 2,38,187Avg Vol 1W: 54,096Avg Vol 1M: 75,34652W Range:₹25.6₹46.34
Key Ratios
Checked just nowMarket Cap₹58 Cr
Current Price₹35.38
Previous Close₹31.46
High / Low (52w)₹46.34 / ₹25.6
Volume2,38,187
Avg Vol (1W)54,096
Avg Vol (1M)75,346
Stock P/E117.93
Book Value₹13.25
Dividend Yield0%
ROE12.92%
ROA112.02%
Revenue (TTM)—
Revenue Growth—
Profit Margin139.86%
Total Debt—
Shares Outstanding2 Cr
Face Value₹10
EPS (TTM)₹0.3
P/B2.67
Debt / Equity0.09
50 DMA₹32.64
200 DMA₹33.31
Day change+12.46%
Price Chart
₹35.38▼ 19.72% · 1Y
2025-09-102026-09-10
20-day avg volume: 82K shares
Pros
- Company is almost debt-free.
- Net profit is growing year over year.
Cons
- Stock trades at a high P/E of 118.
Quarterly Results
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2 Cr | ₹14 Cr | ₹8 Cr | ₹6 Cr | ₹14 Cr | ₹1 Cr | ₹8 Cr | ₹12 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹3 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹2 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹23 Cr | ₹30 Cr | ₹37 Cr | ₹23 Cr | ₹30 Cr | ₹41 Cr | ₹34 Cr | ₹31 Cr |
| EBITDA | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹3 Cr |
| Net Profit | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹3 Cr |
| EPS | 0.3 | 0.74 | 0.77 | 0.44 | 0.34 | 0.44 | 0.34 | 1.71 |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹24 Cr | ₹42 Cr | ₹33 Cr | ₹19 Cr | ₹31 Cr | ₹47 Cr | ₹51 Cr | ₹43 Cr |
| Total Liabilities | ₹11 Cr | ₹27 Cr | ₹17 Cr | ₹2 Cr | ₹14 Cr | ₹29 Cr | ₹32 Cr | ₹21 Cr |
| Equity | ₹14 Cr | ₹15 Cr | ₹16 Cr | ₹17 Cr | ₹17 Cr | ₹18 Cr | ₹19 Cr | ₹22 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | ₹2 Cr | ₹0 Cr | ₹0 Cr | ₹3 Cr | ₹-2 Cr | ₹0 Cr |
| Investing | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr |
| Financing | ₹-1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹3 Cr |
| Free Cash Flow | ₹2 Cr | ₹0 Cr | ₹0 Cr | ₹3 Cr | ₹-2 Cr | ₹0 Cr |
Shareholding
Promoter 46.79% Institutions 0.08% Public 53.13%
Efficiency & Working Capital
ROCE14.1%
Interest Coverage65
Dividend Payout—
Debtor Days355 d
Inventory Days51 d
Payable Days219 d
Cash Conversion Cycle187 d
Working Capital Days406 d
Shareholding Details
As of 2026-06-30
Promoter46.8%
FII0%
DII0.1%
Institutions0.1%
Public53.1%
Promoter Pledge0%
No. of Shareholders24,999
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 46.8% | 46.8% | 46.8% | 46.8% | 46.8% | 46.8% | 46.8% | 46.8% | 46.8% | 46.8% | 46.8% | 46.8% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% |
| Public | 53.1% | 53.1% | 53.1% | 53.1% | 53.1% | 53.1% | 53.1% | 53.1% | 53.1% | 53.1% | 53.1% | 53.1% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 26,123 | 25,864 | 26,581 | 25,480 | 26,422 | 26,114 | 25,914 | 25,685 | 25,196 | 24,825 | 25,356 | 24,999 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Scope Finance Company Private Limited | Shareholding of Promoter and Promoter Group | 13.9% | 22,62,500 |
| Mid (india) Pharmaceuticals Pvt Ltd | Shareholding of Promoter and Promoter Group | 7.2% | 11,75,250 |
| Starline Equifin Private Limited | Public Shareholding | 7.1% | 11,49,872 |
| Cyano Finance And Sales Pvt. Ltd. | Shareholding of Promoter and Promoter Group | 5.4% | 8,76,450 |
| Meena Shah | Shareholding of Promoter and Promoter Group | 4.1% | 6,60,312 |
| Niyati Shah | Shareholding of Promoter and Promoter Group | 4.1% | 6,59,312 |
| Ketan Shah | Shareholding of Promoter and Promoter Group | 3% | 4,93,062 |
| Sandeep Shah | Shareholding of Promoter and Promoter Group | 2.6% | 4,23,812 |
| Romil Shah | Shareholding of Promoter and Promoter Group | 2.4% | 3,82,550 |
| Ksl And Industries Limited | Public Shareholding | 1.9% | 3,08,065 |
| Kishor Himmatsinh Jhala | Public Shareholding | 1.2% | 1,97,836 |
| Smitesh Sanalal Shah | Shareholding of Promoter and Promoter Group | 1.2% | 1,86,662 |
| Gom Industries Ltd | Public Shareholding | 1.1% | 1,80,800 |
| Trupti Shah | Shareholding of Promoter and Promoter Group | 0.6% | 1,01,750 |
| Ritu Shah | Shareholding of Promoter and Promoter Group | 0.6% | 90,100 |
| Manali Simon | Shareholding of Promoter and Promoter Group | 0.5% | 87,200 |
| Meet Shah | Shareholding of Promoter and Promoter Group | 0.5% | 87,200 |
| Rohan Shah | Shareholding of Promoter and Promoter Group | 0.4% | 65,500 |
| Kiran Shah | Shareholding of Promoter and Promoter Group | 0.4% | 63,100 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Ketan Shah | Chairman / Executive Director / M D / Promoter | 2025 |
| Meet Shah | Non-Exec & Non-Independent Dir | 2025 |
| Ashok Kumar Ramawat | Independent Non Exe. Director | 2025 |
| Satish Beohar | Independent Non Exe. Director | 2025 |
| Gayatri Padiyar | Independent Non Exe. Director | 2025 |
| Smitesh Shah | Non-Exec & Non-Independent Dir | 2025 |
| Apoorv Jain | Company Sec. & Compli. Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharma | ₹19 Cr | 66.8% |
| Chemicals | ₹9 Cr | 33.2% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 20 | 16 | 16 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-08-11 | Board Meetings | — |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 8 | 9 |
| 2026 | 0 | 0 | 0 | 0 | 5 | 5 |
| 2026 | 0 | 0 | 0 | 0 | 1 | 2 |
Insider / Designated-Person Trades
2 recent disclosure(s)
NIYATI SHAHDisposal · 32,657
MEENA SHAHAcquisition · 32,657
Substantial Acquisitions (SAST)
3 disclosure(s)
Off Market Gift11/03/2024 · 87,200
Off Market Gift11/03/2024 · 87,200
Off Market Gift11/03/2024 · 87,200
Company Information
Incorporated1985
ChairmanKetan Shah
AuditorMaheshwari & Gupta
Investor Email[email protected]; [email protected]
📍 11/12 Sector E Sanwer Road, Sanwer Road Industrial Area, Indore, Madhya Pradesh, 452015
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search